Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
small molecule |
| gptkbp:CASNumber |
1446334-54-8
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:developedBy |
gptkb:Bayer
|
| gptkbp:hasMolecularFormula |
C23H19FN6O2
|
| https://www.w3.org/2000/01/rdf-schema#label |
rogaratinib
|
| gptkbp:investigatedBy |
gptkb:urothelial_carcinoma
solid tumors |
| gptkbp:mechanismOfAction |
FGFR inhibitor
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL3989989
71587768 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
BAY 1163877
|
| gptkbp:target |
gptkb:FGFR3
gptkb:FGFR1 gptkb:FGFR4 gptkb:FGFR2 |
| gptkbp:bfsParent |
gptkb:FGFR1
|
| gptkbp:bfsLayer |
6
|